GOLGA5

gene
On this page

Also known as ret-IIgolgin-84rfg5GOLIM5

Summary

GOLGA5 (golgin A5, HGNC:4428) is a protein-coding gene on chromosome 14q32.12, encoding Golgin subfamily A member 5 (Q8TBA6). Involved in maintaining Golgi structure.

The Golgi apparatus, which participates in glycosylation and transport of proteins and lipids in the secretory pathway, consists of a series of stacked cisternae (flattened membrane sacs). Interactions between the Golgi and microtubules are thought to be important for the reorganization of the Golgi after it fragments during mitosis. This gene encodes one of the golgins, a family of proteins localized to the Golgi. This protein is a coiled-coil membrane protein that has been postulated to play a role in vesicle tethering and docking. Translocations involving this gene and the ret proto-oncogene have been found in tumor tissues; the chimeric sequences have been designated RET-II and PTC5. A pseudogene of this gene is located on the short arm of chromosome 5.

Source: NCBI Gene 9950 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 110 total
  • MANE Select transcript: NM_005113

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:4428
Approved symbolGOLGA5
Namegolgin A5
Location14q32.12
Locus typegene with protein product
StatusApproved
Aliasesret-II, golgin-84, rfg5, GOLIM5
Ensembl geneENSG00000066455
Ensembl biotypeprotein_coding
OMIM606918
Entrez9950

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 14 protein_coding, 1 retained_intron

ENST00000163416, ENST00000554700, ENST00000555793, ENST00000868374, ENST00000868375, ENST00000868376, ENST00000868377, ENST00000868378, ENST00000868379, ENST00000868380, ENST00000868381, ENST00000868382, ENST00000868383, ENST00000868384, ENST00000868385

RefSeq mRNA: 1 — MANE Select: NM_005113 NM_005113

CCDS: CCDS9905

Canonical transcript exons

ENST00000163416 — 13 exons

ExonStartEnd
ENSE000003730209281155192811754
ENSE000003730249283312292833347
ENSE000006598819280673692806963
ENSE000006598829280930092809519
ENSE000006598839281025492810377
ENSE000006598919281625192816421
ENSE000006598929281970892819836
ENSE000006598939282454692824644
ENSE000006598959283555992835664
ENSE000006598969283738692837449
ENSE000008087009279740892797981
ENSE000017625329283936692839947
ENSE000025070409279430592794456

Expression profiles

Bgee: expression breadth ubiquitous, 290 present calls, max score 96.05.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 26.4868 / max 215.6569, expressed in 1800 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
14114624.85861796
1411450.7157455
1411470.4804285
1411440.4320209

Top tissues by expression

293 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065596.05gold quality
islet of LangerhansUBERON:000000693.58gold quality
calcaneal tendonUBERON:000370193.34gold quality
parotid glandUBERON:000183193.10gold quality
olfactory segment of nasal mucosaUBERON:000538692.98gold quality
rectumUBERON:000105292.86gold quality
skin of hipUBERON:000155492.84gold quality
oocyteCL:000002392.73gold quality
right lobe of liverUBERON:000111492.48gold quality
body of pancreasUBERON:000115092.19gold quality
nasal cavity mucosaUBERON:000182692.17gold quality
corpus epididymisUBERON:000435992.07gold quality
placentaUBERON:000198792.05gold quality
pancreasUBERON:000126492.01gold quality
mucosa of sigmoid colonUBERON:000499391.51gold quality
epithelium of nasopharynxUBERON:000195191.41gold quality
nasopharynxUBERON:000172891.40gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099191.37gold quality
colonic mucosaUBERON:000031791.09gold quality
deciduaUBERON:000245091.09gold quality
liverUBERON:000210791.05gold quality
stromal cell of endometriumCL:000225591.01gold quality
jejunal mucosaUBERON:000039991.00gold quality
oral cavityUBERON:000016790.88gold quality
saliva-secreting glandUBERON:000104490.77gold quality
gingival epitheliumUBERON:000194990.76gold quality
lower lobe of lungUBERON:000894990.75gold quality
lower esophagus mucosaUBERON:003583490.74gold quality
gingivaUBERON:000182890.72gold quality
gall bladderUBERON:000211090.68gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes8.69

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

48 targeting GOLGA5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3924100.0072.092394
HSA-MIR-3163100.0077.238605
HSA-MIR-340-5P100.0072.504437
HSA-MIR-607799.9968.042299
HSA-MIR-1213699.9872.815713
HSA-MIR-50799.9770.111915
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-55799.9670.011640
HSA-LET-7C-3P99.9573.422862
HSA-MIR-651-3P99.9473.485177
HSA-MIR-6753-3P99.9366.57637
HSA-MIR-7107-3P99.9366.73627
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-338-5P99.9272.342951
HSA-MIR-345-3P99.8970.231421
HSA-MIR-548E-5P99.8972.734486
HSA-LET-7A-2-3P99.8770.531921
HSA-MIR-806799.8669.592260
HSA-LET-7G-3P99.8570.431929
HSA-MIR-607999.8468.541170
HSA-MIR-431999.7669.832586
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-4446-5P99.7269.192544
HSA-MIR-4755-5P99.7170.342716
HSA-MIR-5006-3P99.7170.262728
HSA-MIR-518A-5P99.7069.012209
HSA-MIR-52799.7069.012209
HSA-MIR-670-5P99.6769.941565
HSA-MIR-7-5P99.6770.531809

Literature-anchored findings (GeneRIF, showing 2)

  • involved in generating and maintaining the architecture of the Golgi apparatus (PMID:12656988)
  • Golgin-84 on coat protein I vesicles interacts with the conserved oligomeric Golgi complex before SNARE assembly. (PMID:20874812)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriogolga5ENSDARG00000039279
mus_musculusGolga5ENSMUSG00000021192
rattus_norvegicusGolga5ENSRNOG00000007699
drosophila_melanogasterGolgin84FBGN0039188
caenorhabditis_elegansgolg-5WBGENE00011975

Protein

Protein identifiers

Golgin subfamily A member 5Q8TBA6 (reviewed: Q8TBA6)

Alternative names: Cell proliferation-inducing gene 31 protein, Golgin-84, Protein Ret-II, RET-fused gene 5 protein

All UniProt accessions (2): Q8TBA6, H0YK03

UniProt curated annotations — full annotation on UniProt →

Function. Involved in maintaining Golgi structure. Stimulates the formation of Golgi stacks and ribbons. Involved in intra-Golgi retrograde transport.

Subunit / interactions. Homodimer. Interacts with RAB1A that has been activated by GTP-binding, and possibly also with OCRL1. Interacts with isoform CASP of CUX1.

Subcellular location. Golgi apparatus membrane.

Tissue specificity. Ubiquitous. Highly expressed in seminiferous tubules and Leydig cells in testis, and detected at much lower levels in the other tissues tested. Expression is very low or not detectable in spermatozoa.

Post-translational modifications. Highly phosphorylated during mitosis. Phosphorylation is barely detectable during interphase.

Disease relevance. A chromosomal aberration involving GOLGA5 is found in papillary thyroid carcinomas (PTCs). Translocation t(10;14)(q11;q32) with RET. The translocation generates the RET/GOLGA5 (PTC5) oncogene.

Isoforms (2)

UniProt IDNamesCanonical?
Q8TBA6-11yes
Q8TBA6-22

RefSeq proteins (1): NP_005104* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR019177Golgin_subfamily_A_member_5Family

Pfam: PF09787

UniProt features (21 total): compositionally biased region 4, modified residue 3, splice variant 2, sequence variant 2, sequence conflict 2, topological domain 2, initiator methionine 1, chain 1, site 1, transmembrane region 1, region of interest 1, coiled-coil region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8TBA6-F172.600.47

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 497–498 (breakpoint for translocation to form ret-golga5 oncogene)

Post-translational modifications (3): 2, 89, 116

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-6811438Intra-Golgi traffic

MSigDB gene sets: 130 (showing top): MODULE_255, MODULE_317, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOMF_GTPASE_BINDING, GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT, DAWSON_METHYLATED_IN_LYMPHOMA_TCL1, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN, E4F1_Q6, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, DANG_BOUND_BY_MYC, chr14q32, GOBP_GOLGI_ORGANIZATION, GOCC_GOLGI_STACK, GOCC_GOLGI_CISTERNA

GO Biological Process (3): retrograde transport, vesicle recycling within Golgi (GO:0000301), Golgi organization (GO:0007030), Golgi vesicle transport (GO:0048193)

GO Molecular Function (2): small GTPase binding (GO:0031267), protein homodimerization activity (GO:0042803)

GO Cellular Component (6): Golgi membrane (GO:0000139), Golgi apparatus (GO:0005794), cis-Golgi network (GO:0005801), membrane (GO:0016020), transport vesicle (GO:0030133), Golgi cisterna (GO:0031985)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Intra-Golgi and retrograde Golgi-to-ER traffic1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
Golgi apparatus2
endomembrane system2
intracellular membrane-bounded organelle2
intra-Golgi vesicle-mediated transport1
organelle organization1
endomembrane system organization1
vesicle-mediated transport1
GTPase binding1
identical protein binding1
protein dimerization activity1
bounding membrane of organelle1
cytoplasm1
cellular anatomical structure1
cytoplasmic vesicle1
Golgi stack1
Golgi apparatus subcompartment1

Protein interactions and networks

STRING

1034 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
GOLGA5COG7P83436930
GOLGA5GOLGB1Q14789920
GOLGA5CUX1P39880778
GOLGA5GORASP1Q9BQQ3773
GOLGA5OCRLQ01968766
GOLGA5TRIP11Q15643739
GOLGA5COG3Q96JB2731
GOLGA5COG8Q96MW5709
GOLGA5RAB1AP11476693
GOLGA5BLZF1Q9H2G9693
GOLGA5GOLGA2Q08379692
GOLGA5GORASP2Q9H8Y8683
GOLGA5TRIM33Q9UPN9683
GOLGA5COG5Q9UP83668
GOLGA5COG6Q9Y2V7646

IntAct

229 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
CD27TCAF2psi-mi:“MI:0914”(association)0.640
CHST14CANXpsi-mi:“MI:0914”(association)0.640
NIPAL1ESYT2psi-mi:“MI:0914”(association)0.640
CERS2ATP5F1Bpsi-mi:“MI:0914”(association)0.640
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
LPAR1TMEM223psi-mi:“MI:0914”(association)0.530
IPPKTMEM223psi-mi:“MI:0914”(association)0.530
C3AR1TMEM120Bpsi-mi:“MI:0914”(association)0.530
POMKTMEM120Bpsi-mi:“MI:0914”(association)0.530
HTR2CKLRG2psi-mi:“MI:0914”(association)0.530
B4GALT3SLC19A2psi-mi:“MI:0914”(association)0.530
SPINT2UPK3BL1psi-mi:“MI:0914”(association)0.530
CCDC107PLD2psi-mi:“MI:0914”(association)0.530
SPPL2BUQCRQpsi-mi:“MI:0914”(association)0.530
ODAD3CCDC22psi-mi:“MI:0914”(association)0.530
GPR161USP12psi-mi:“MI:0914”(association)0.530
ASGR2MT-CO1psi-mi:“MI:0914”(association)0.530
STSGJA1psi-mi:“MI:0914”(association)0.530
AOC2GOLGA5psi-mi:“MI:0914”(association)0.530
TMEM9ESYT2psi-mi:“MI:0914”(association)0.530
YIPF3TMEM120Bpsi-mi:“MI:0914”(association)0.530

BioGRID (349): GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Proximity Label-MS), GOLGA5 (Proximity Label-MS), GOLGA5 (Affinity Capture-MS), GOLGA5 (Affinity Capture-MS)

ESM2 similar proteins: B0WPU9, B3MNR6, B3NL60, B4G831, B4I5P7, B4N1C2, B4PAF2, B4Q9E6, B6MFW3, F1MA98, F6ZDS4, G0SA56, O61493, O76878, P12270, P16568, P70403, P85001, Q13948, Q17AF4, Q24185, Q29N92, Q2T9W6, Q3ZU82, Q4V7E8, Q4WDD7, Q5EE04, Q5R8V1, Q5TZ80, Q5ZJ27, Q6GNT7, Q6GQ73, Q6IR70, Q6NRB0, Q6ZMI0, Q7PWT9, Q7SXE4, Q86VS8, Q8BIL5, Q8BUK6

Diamond homologs: Q3ZU82, Q5JLY8, Q6GNT7, Q7SXE4, Q8S8N9, Q8SZ63, Q8TBA6, Q9QYE6, B0F9L7

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 220 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Class A/1 (Rhodopsin-like receptors)157.0×2e-06
COPII-mediated vesicle transport66.2×1e-02
GPCR ligand binding156.1×7e-06
Signaling by GPCR153.8×1e-03
GPCR downstream signalling133.6×4e-03
G alpha (i) signalling events143.5×3e-03

GO biological processes:

GO termPartnersFoldFDR
Golgi to plasma membrane transport616.7×4e-04
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway1010.8×3e-05
endocytic recycling79.3×2e-03
positive regulation of cytosolic calcium ion concentration116.4×4e-04
phospholipase C-activating G protein-coupled receptor signaling pathway95.9×4e-03
adenylate cyclase-activating G protein-coupled receptor signaling pathway105.6×2e-03
protein transport204.3×3e-05
G protein-coupled receptor signaling pathway213.8×9e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

110 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance87
Likely benign4
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2311 predictions. Top by Δscore:

VariantEffectΔscore
14:92797403:TACA:Tacceptor_loss1.0000
14:92797405:CA:Cacceptor_loss1.0000
14:92797406:A:ACacceptor_loss1.0000
14:92797407:G:Cacceptor_loss1.0000
14:92806734:A:ACacceptor_loss1.0000
14:92806734:A:AGacceptor_gain1.0000
14:92806735:G:GTacceptor_gain1.0000
14:92806735:GA:Gacceptor_gain1.0000
14:92806735:GAA:Gacceptor_gain1.0000
14:92806735:GAAGC:Gacceptor_gain1.0000
14:92806896:G:GTdonor_gain1.0000
14:92806897:A:Tdonor_gain1.0000
14:92806900:G:GTdonor_gain1.0000
14:92806904:T:Gdonor_gain1.0000
14:92806960:GAAG:Gdonor_gain1.0000
14:92806961:A:Tdonor_gain1.0000
14:92809298:A:AGacceptor_gain1.0000
14:92809299:G:GGacceptor_gain1.0000
14:92809518:CGGTA:Cdonor_loss1.0000
14:92809520:G:GAdonor_loss1.0000
14:92809520:G:GGdonor_gain1.0000
14:92809521:T:Gdonor_loss1.0000
14:92810252:A:AGacceptor_gain1.0000
14:92810253:G:Aacceptor_loss1.0000
14:92810253:G:GGacceptor_gain1.0000
14:92810253:GA:Gacceptor_gain1.0000
14:92810253:GAAT:Gacceptor_gain1.0000
14:92810253:GAATA:Gacceptor_gain1.0000
14:92810358:A:Tdonor_gain1.0000
14:92811549:A:AGacceptor_gain1.0000

AlphaMissense

4822 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
14:92811750:T:CL439P1.000
14:92833183:T:CL594P1.000
14:92833195:T:CL598P1.000
14:92797481:T:CL15S0.999
14:92811737:G:CA435P0.999
14:92811738:C:AA435D0.999
14:92816251:T:CS441P0.999
14:92833171:G:CR590P0.999
14:92833174:T:CL591P0.999
14:92833207:A:CQ602P0.999
14:92833225:T:CL608P0.999
14:92835643:C:AA677D0.999
14:92835652:T:AI680N0.999
14:92837406:T:CL691P0.999
14:92839381:T:AW711R0.999
14:92839381:T:CW711R0.999
14:92797460:C:AA8D0.998
14:92809458:G:CA311P0.998
14:92816256:G:CK442N0.998
14:92816256:G:TK442N0.998
14:92824634:T:CL570P0.998
14:92833246:T:CL615P0.998
14:92833258:T:CL619P0.998
14:92835640:C:AA676D0.998
14:92835655:A:CD681A0.998
14:92835655:A:TD681V0.998
14:92837394:T:CL687P0.998
14:92837396:G:AG688R0.998
14:92837396:G:CG688R0.998
14:92837397:G:AG688E0.998

dbSNP variants (sampled 300 via entrez): RS1000028225 (14:92831992 T>G), RS1000042338 (14:92795931 C>G), RS1000109764 (14:92798848 C>A,T), RS1000157705 (14:92835902 A>G), RS1000199042 (14:92793733 A>G), RS1000222328 (14:92833895 TA>T,TAA), RS1000240339 (14:92804938 G>A,T), RS1000253379 (14:92825684 G>C), RS1000293082 (14:92835435 T>C), RS1000442117 (14:92802999 T>G), RS1000532377 (14:92837233 A>G), RS1000625676 (14:92837005 A>G), RS1000644598 (14:92794570 C>G), RS1000651000 (14:92797370 C>T), RS1000655002 (14:92796068 C>T)

Disease associations

OMIM: gene MIM:606918 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST005951_7Body mass index4.000000e-08

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004340body mass index

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression, decreases methylation3
Cyclosporineincreases expression3
sodium arsenitedecreases expression, increases expression2
Air Pollutantsaffects expression, increases abundance, decreases expression2
FR900359increases phosphorylation1
dicrotophosdecreases expression1
afimoxifenedecreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
perfluorooctane sulfonic acidincreases expression1
CGP 52608affects binding, increases reaction1
K 7174increases expression1
Sunitinibincreases expression1
Fulvestrantdecreases expression1
Air Pollutants, Occupationaldecreases expression1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Estradiolincreases expression1
Manganeseaffects expression1
Nickeldecreases expression1
Ozoneaffects expression, increases abundance1
Tobacco Smoke Pollutionincreases expression1
Tunicamycinincreases expression1
Aflatoxin B1decreases methylation1
Sodium Seleniteincreases expression1
Thapsigarginincreases expression1
Copper Sulfatedecreases expression1
Lactic Aciddecreases expression1
Raloxifene Hydrochloridedecreases expression1
Particulate Matterdecreases expression, increases abundance1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B2XZAbcam HEK293T GOLGA5 KOTransformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.